Generic Sofosbuvir DAAs in HCV-infected Patients With CKD Generic Sofosbuvir DAAs in HCV-infected Patients With CKD

This study evaluated the efficacy and safety of generic versions of sofosbuvir in combination with ribavirin, ledipasvir or daclatasvir in HCV-infected patients with CKD.Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news